{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:44:47Z","timestamp":1790934287914,"version":"4.1.0"},"reference-count":105,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Salivary gland cancers (SGCs) are rare and heterogeneous tumours, making the identification of reliable prognostic biomarkers challenging. MicroRNAs (miRNAs) regulate post-transcriptional gene expression and may play important roles in tumour progression and treatment response. This systematic review aims to identify and summarize the current evidence on miRNA dysregulation in SGCs, with a particular focus on their prognostic relevance and therapeutic potential. A systematic search of PubMed\/MEDLINE, Embase, Web of Science, and the Cochrane Library was conducted up to 3 December 2025, following PRISMA guidelines and a pre-registered protocol (CRD420251231827). Observational cohort and cross-sectional studies reporting microRNA dysregulation in human salivary gland tissues with prognostic assessment were included. Risk of bias was assessed using the Quality in Prognosis Studies (QUIPS) tool. Due to considerable heterogeneity, a narrative synthesis was conducted. Twenty studies published between 2013 and 2025 that fulfilled the search criteria were further analyzed. Based on the currently available evidence, dysregulation of miRNAs associated with prognosis has been identified only in adenoid cystic carcinoma (AdCC) and mucoepidermoid carcinoma (MEC). Most studies originated from Asia and used qRT-PCR for miRNA assessment. Most researchers focused on the evaluation of selected candidate miRNAs, rather than conducting comprehensive miRNA profiling approaches in relation to prognosis. Several distinct dysregulated miRNAs were identified across the studies. Among them, miR-9, miR-21, miR-24 miR-29, miR-34c-5p, miR-125a-5p, miR-143, miR-145 and miR-205 were reported in more than one study and linked to clinicopathological advancement and a more aggressive disease course, thus leading to a poorer outcome. MiRNAs appear to represent promising prognostic biomarkers, either as independent predictors or in combination with established clinicopathological features. However, current evidence remains limited to selected histological subtypes and relatively small patient cohorts. Further well-designed studies with long-term follow-up are required. Moreover, comprehensive miRNA profiling with prognosis assessment is necessary before specific miRNAs could be reliably established as biomarkers and utilized in daily clinical practice.<\/jats:p>","DOI":"10.3390\/ijms27146101","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:27:31Z","timestamp":1783531651000},"page":"6101","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MicroRNAs in Salivary Gland Cancers Associated with Poor Prognosis: A Systematic Review"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8763-2347","authenticated-orcid":false,"given":"Julia","family":"Pikul","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-132X","authenticated-orcid":false,"given":"Maja","family":"Cie\u015blik","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Medical University of Warsaw, 02-091 Warsaw, Poland"},{"name":"Doctoral School, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazimierz","family":"Niemczyk","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4012-8271","authenticated-orcid":false,"given":"Anna","family":"Rzepakowska","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"102959","DOI":"10.1016\/j.critrevonc.2020.102959","article-title":"Major and minor salivary gland tumours","volume":"152","author":"Gatta","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12105-022-01420-1","article-title":"Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands","volume":"16","author":"Hyrcza","year":"2022","journal-title":"Head Neck Pathol."},{"key":"ref_3","unstructured":"WHO Classiffcation of Tumours Editorial Board (2022). Head and Neck tumours. WHO Classifcation of Tumours Series, IARC. [5th ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/PAS.0000000000001218","article-title":"Misinterpreted Myoepithelial Carcinoma of Salivary Gland: A Challenging and Potentially Significant Pitfall","volume":"43","author":"Xu","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12105-021-01346-0","article-title":"Myoepithelial Carcinoma Ex-Pleomorphic Adenoma: A Rare Pathology Misdiagnosed as Pleomorphic Adenoma; With a Novel TERT Promoter Mutation and High PD-L1 Expression","volume":"16","author":"Cormier","year":"2022","journal-title":"Head Neck Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/his.14322","article-title":"Pleomorphic adenoma: The great mimicker of malignancy","volume":"79","author":"Franchi","year":"2021","journal-title":"Histopathology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.joms.2022.08.007","article-title":"Survival Outcome of Salivary Gland Carcinoma: A 50-Year Retrospective Study With Long-Term Follow-up","volume":"80","author":"Jia","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Liu, F., Chu, Y., Zheng, Q., Hu, Y., Wang, Y., Qin, L., Fu, S., and Wang, S. (2024). Major and minor perineural invasion in salivary gland cancer. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1466196"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/hed.10400","article-title":"Salivary gland carcinoma: Independent prognostic factors for locoregional control, distant metastases, and overall survival: Results of the Dutch head and neck oncology cooperative group","volume":"26","author":"Terhaard","year":"2004","journal-title":"Head Neck"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1007\/s00405-024-08650-9","article-title":"Oncologic outcomes of the most prevalent major salivary gland cancers: Retrospective cohort study from single center","volume":"281","author":"Kucharska","year":"2024","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00428-015-1760-5","article-title":"Pattern of recurrent disease in major salivary gland adenocystic carcinoma","volume":"467","author":"Hirvonen","year":"2015","journal-title":"Virchows Arch."},{"key":"ref_12","unstructured":"Young, A., and Okuyemi, O.T. (2022). Malignant Salivary Gland Tumors. StatPearls, StatPearls Publishing LLC."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105764","DOI":"10.1016\/j.oraloncology.2022.105764","article-title":"Baseline prognostic factors affecting survival in recurrent and\/or metastatic salivary gland adenoid cystic carcinoma","volume":"126","author":"Lombardi","year":"2022","journal-title":"Oral. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.oraloncology.2014.10.007","article-title":"Histopathological grading of adenoid cystic carcinoma of the head and neck: Analysis of currently used grading systems and proposal for a simplified grading scheme","volume":"51","author":"Witte","year":"2015","journal-title":"Oral. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0714.1990.tb00806.x","article-title":"Prognostic factors for adenoid cystic carcinoma of the head and neck: A retrospective evaluation of 96 cases","volume":"19","author":"Hamper","year":"1990","journal-title":"J. Oral. Pathol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/PAP.0000000000000298","article-title":"High-grade Transformation\/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance","volume":"28","author":"Skalova","year":"2021","journal-title":"Adv. Anat. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.oraloncology.2015.10.002","article-title":"Salivary adenoid cystic carcinoma in Denmark 1990\u20132005: Outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA)","volume":"51","author":"Krogdahl","year":"2015","journal-title":"Oral Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"E2041","DOI":"10.1002\/hed.24375","article-title":"High-grade histology as predictor of early distant metastases and decreased disease-free survival in salivary gland cancer irrespective of tumor subtype","volume":"38","author":"Haderlein","year":"2016","journal-title":"Head Neck"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.oraloncology.2009.07.001","article-title":"Perineural invasion in adenoid cystic carcinoma of the salivary glands: A valid prognostic indicator?","volume":"45","author":"Barrett","year":"2009","journal-title":"Oral Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"105937","DOI":"10.1016\/j.oraloncology.2022.105937","article-title":"The role of perineural invasion in parotid malignancy outcomes: A systematic review and meta-analysis","volume":"130","author":"Kazemian","year":"2022","journal-title":"Oral Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1245\/s10434-016-5356-3","article-title":"Risk Factors and Survival Associated with Distant Metastasis in Patients with Carcinoma of the Salivary Gland","volume":"23","author":"Nam","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Pikul, J., Machnicki, M.M., Rzepakowska, A., Winiarska, N., Chudy, A., Moskowicz, A., Kr\u00f3l, K., Fus, \u0141., Kostrzewa, G., and Stok\u0142osa, T. (2025). Potentially actionable molecular alterations in particular related to poor oncologic outcomes in salivary gland carcinomas. BMC Cancer, 25.","DOI":"10.1186\/s12885-024-13421-0"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100602","DOI":"10.1016\/j.esmoop.2022.100602","article-title":"Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"7","author":"Skalova","year":"2022","journal-title":"ESMO Open"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.21.00449","article-title":"Management of Salivary Gland Malignancy: ASCO Guideline","volume":"39","author":"Geiger","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5114\/wo.2024.144288","article-title":"Molecular landscape of salivary gland malignancies. What is already known?","volume":"28","author":"Pikul","year":"2024","journal-title":"Contemp. Oncol.\/Wsp\u00f3\u0142czesna Onkol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: Biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Smolarz, B., Durczy\u0144ski, A., Romanowicz, H., Szy\u0142\u0142o, K., and Hogendorf, P. (2022). miRNAs in Cancer (Review of Literature). Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052805"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12105-023-01603-4","article-title":"Dynamic Role of miRNAs in Salivary Gland Carcinomas: From Biomarkers to Therapeutic Targets","volume":"18","author":"Kimura","year":"2024","journal-title":"Head Neck Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Menon, A., Abd-Aziz, N., Khalid, K., Poh, C.L., and Naidu, R. (2022). miRNA: A Promising Therapeutic Target in Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911502"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/ijc.24638","article-title":"Epigenetic regulation of microRNA expression in colorectal cancer","volume":"125","author":"Bandres","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.4161\/epi.6.10.16535","article-title":"Aberrant hypermethylation of miR-9 genes in gastric cancer","volume":"6","author":"Tsai","year":"2011","journal-title":"Epigenetics"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Naakka, E., Barros-Filho, M.C., Adnan-Awad, S., Al-Samadi, A., Marchi, F.A., Kuasne, H., Korelin, K., Suleymanova, I., Brown, A.L., and Scapulatempo-Neto, C. (2021). miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.786150"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bjorl.2016.03.013","article-title":"Comparison of microRNA profiles between benign and malignant salivary gland tumors in tissue, blood and saliva samples: A prospective, case-control study","volume":"83","author":"Cinpolat","year":"2017","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_37","first-page":"e1230","article-title":"PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res. Synth. Methods"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00428-018-2423-0","article-title":"MicroRNA dysregulation in adenoid cystic carcinoma of the salivary gland in relation to prognosis and gene fusion status: A cohort study","volume":"473","author":"Andreasen","year":"2018","journal-title":"Virchows Arch."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cre2.678","article-title":"Interactive role of miR-29, miR-93, miR-205, and VEGF in salivary adenoid cystic carcinoma","volume":"9","author":"Bayat","year":"2023","journal-title":"Clin. Exp. Dent. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbrc.2023.03.015","article-title":"miR-183-5p overexpression orchestrates collective invasion in salivary adenoid cystic carcinoma through the FAT1\/YAP1 signaling pathway","volume":"655","author":"Chen","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"101868","DOI":"10.1016\/j.tranon.2023.101868","article-title":"Hypoxia induced cell dormancy of salivary adenoid cystic carcinoma through miR-922\/DEC2 axis","volume":"40","author":"Dai","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3892\/ijo.2020.5069","article-title":"MicroRNA-103a-3p promotes metastasis by targeting TPD52 in salivary adenoid cystic carcinoma","volume":"57","author":"Fu","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/labinvest.2015.105","article-title":"miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma","volume":"95","author":"Jiang","year":"2015","journal-title":"Lab. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s11033-021-07033-1","article-title":"EMT in salivary gland tumors: The expression of microRNAs miR-155 and miR-200c is associated with clinical-pathological parameters","volume":"49","author":"Kerche","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10735-025-10504-5","article-title":"miR-429 suppresses progression and metastasis of salivary adenoid cystic carcinoma by targeting ZEB1","volume":"56","author":"Li","year":"2025","journal-title":"J. Mol. Histol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1039\/D5TB00611B","article-title":"Injectable thermosensitive hydrogel-encapsulated paclitaxel liposomes enriched with miR-455-3p antagomir for dormancy therapy of salivary adenoid cystic carcinoma","volume":"13","author":"Li","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/odi.13841","article-title":"miR-5191 acts as a tumor suppressor in salivary adenoid cystic carcinoma by targeting Notch-2","volume":"28","author":"Li","year":"2022","journal-title":"Oral. Dis."},{"key":"ref_50","first-page":"1101","article-title":"Down-regulation of miR-125a-5p is associated with salivary adenoid cystic carcinoma progression via targeting p38\/JNK\/ERK signal pathway","volume":"9","author":"Liang","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Mitani, Y., Roberts, D.B., Fatani, H., Weber, R.S., Kies, M.S., Lippman, S.M., and El-Naggar, A.K. (2013). MicroRNA profiling of salivary adenoid cystic carcinoma: Association of miR-17-92 upregulation with poor outcome. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066778"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.prp.2017.10.012","article-title":"MicroRNAs expression pattern related to mast cell activation and angiogenesis in paraffin-embedded salivary gland tumors","volume":"213","author":"Santos","year":"2017","journal-title":"Pathol. Res. Pract."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-015-0344-y","article-title":"MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3","volume":"14","author":"Sun","year":"2015","journal-title":"Mol. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Trevizani, M.E.S., Marchi, F.A., Bizinelli, D., Oliveira, K.K., Mariano, F.V., Nagano, C.P., Costa, F.D., Pinto, C.A.L., Kowalski, L.P., and Louren\u00e7o, S.V. (2025). MicroRNA Profiles Distinguishing Metastatic from Non-Metastatic Salivary Mucoepidermoid Carcinoma. J. Clin. Med., 14.","DOI":"10.3390\/jcm14144957"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbrc.2018.04.122","article-title":"Genome-wide profiles of metastasis-associated mRNAs and microRNAs in salivary adenoid cystic carcinoma","volume":"500","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jjco\/hyx073","article-title":"miR-582-5p inhibits invasion and migration of salivary adenoid cystic carcinoma cells by targeting FOXC1","volume":"47","author":"Wang","year":"2017","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.ymthe.2018.08.018","article-title":"Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K\/Akt and MEK\/Erk Signaling","volume":"26","author":"Xie","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Zanon, M.F., Scapulatempo-Neto, C., Gama, R.R., Marques, M.M.C., Reis, R.M., and Evangelista, A.F. (2023). Identification of MicroRNA Expression Profiles Related to the Aggressiveness of Salivary Gland Adenoid Cystic Carcinomas. Genes, 14.","DOI":"10.3390\/genes14061220"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.biopha.2018.05.157","article-title":"Effect of simvastatin and microRNA-21 inhibitor on metastasis and progression of human salivary adenoid cystic carcinoma","volume":"105","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_60","first-page":"4237","article-title":"Role of miR-21 in the growth and metastasis of human salivary adenoid cystic carcinoma","volume":"17","author":"Yan","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejcb.2012.11.002","article-title":"MiR-205 in cancer: An angel or a devil?","volume":"92","author":"Qin","year":"2013","journal-title":"Eur. J. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"140134","DOI":"10.1016\/j.ijbiomac.2025.140134","article-title":"MiRNA-155: A double-edged sword in colorectal cancer progression and drug resistance mechanisms","volume":"299","author":"Hussen","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"153405","DOI":"10.1016\/j.prp.2021.153405","article-title":"MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer","volume":"220","author":"Li","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gene.2019.02.066","article-title":"MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer","volume":"700","author":"Zhang","year":"2019","journal-title":"Gene"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"142","DOI":"10.14712\/fb2019065030142","article-title":"Deregulation of Selected MicroRNAs in Sinonasal Squamous Cell Carcinoma: Searching for Potential Prognostic Biomarkers","volume":"65","author":"Laco","year":"2019","journal-title":"Folia Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.omto.2018.12.011","article-title":"A Systematic Review of miR-29 in Cancer","volume":"12","author":"Kwon","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Ragab, M.A., Fathy, N., Attia, Y.M., Amer, E.A., and Fahim, S.A. (2026). The paradox of miR-107 in oncology: Dual roles as a tumor suppressor and oncomiR. Cancer Gene Ther.","DOI":"10.1038\/s41417-026-01042-7"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Annese, T., Tamma, R., De Giorgis, M., and Ribatti, D. (2020). microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.581007"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer","volume":"76","author":"Svoronos","year":"2016","journal-title":"Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3921258","DOI":"10.1155\/2017\/3921258","article-title":"Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma","volume":"2017","author":"Re","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00280-013-2108-y","article-title":"Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel","volume":"71","author":"Wu","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.bbrc.2018.09.147","article-title":"MiR-429 suppresses neurotrophin-3 to alleviate perineural invasion of pancreatic cancer","volume":"505","author":"Liu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Yang, L., Li, H., and Huang, A. (2020). MiR-429 and MiR-143-3p Function as Diagnostic and Prognostic Markers for Osteosarcoma. Clin. Lab., 66.","DOI":"10.7754\/Clin.Lab.2020.191237"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/or.2024.8772","article-title":"Biological functions and potential mechanisms of miR-143-3p in cancers (Review)","volume":"52","author":"Wu","year":"2024","journal-title":"Oncol. Rep."},{"key":"ref_75","first-page":"6739","article-title":"MiR-145: A potential biomarker of cancer migration and invasion","volume":"11","author":"Xu","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopha.2014.12.019","article-title":"Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer","volume":"69","author":"Shen","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jcma.2017.01.003","article-title":"MicroRNA-21 promotes perineural invasion and impacts survival in patients with oral carcinoma","volume":"80","author":"Yu","year":"2017","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Hurn\u00edk, P., Chyra, Z., \u0160ev\u010d\u00edkov\u00e1, T., \u0160temb\u00edrek, J., Trtkov\u00e1, K.S., Gaykalova, D.A., Buchtov\u00e1, M., and Hrub\u00e1, E. (2022). Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.848557"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"15384","DOI":"10.18632\/aging.203097","article-title":"CXCR5 induces perineural invasion of salivary adenoid cystic carcinoma by inhibiting microRNA-187","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1007\/s12094-023-03182-w","article-title":"Induction of perineural invasion in salivary adenoid cystic carcinoma by circular RNA RNF111","volume":"25","author":"Su","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e16685","DOI":"10.1097\/MD.0000000000016685","article-title":"Prognostic and clinicopathologic significance of MicroRNA-125a-5p in cancers: A meta-analysis","volume":"98","author":"Ye","year":"2019","journal-title":"Medicine"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Zarlashat, Y., Hal\u00e1sz, J., and D\u00f3sa, E. (2025). Dysregulation of MicroRNAs in Hepatocellular Carcinoma: Targeting Oncogenic Signaling Pathways for Innovative Therapies. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26178365"},{"key":"ref_83","first-page":"7314","article-title":"MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5","volume":"23","author":"Wei","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.2147\/CMAR.S187109","article-title":"Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma","volume":"10","author":"Xie","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Mariani, M., Castagna, C., Boccia, S., and Pastorino, R. (2021). The Prognostic Role of Micro-RNAs in Head and Neck Cancers: An Umbrella Review. J. Pers. Med., 11.","DOI":"10.3390\/jpm11080821"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"\u0160imi\u0107, I., Bo\u017einovi\u0107, K., Ga\u0161perov, N.M., Kordi\u0107, M., Pe\u0161ut, E., Manojlovi\u0107, L., Grce, M., Dediol, E., and Sabo, I.l. (2023). Head and Neck Cancer Patients\u2019 Survival According to HPV Status, miRNA Profiling, and Tumour Features-A Cohort Study. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043344"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Hedb\u00e4ck, N., Jensen, D.H., Specht, L., Fiehn, A.M., Therkildsen, M.H., Friis-Hansen, L., Dabelsteen, E., and von Buchwald, C. (2014). MiR-21 expression in the tumor stroma of oral squamous cell carcinoma: An independent biomarker of disease free survival. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095193"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7314\/APJCP.2013.14.2.829","article-title":"MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis","volume":"14","author":"Huang","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e7085","DOI":"10.1097\/MD.0000000000007085","article-title":"MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis","volume":"96","author":"Mao","year":"2017","journal-title":"Medicine"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ijc.28399","article-title":"Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells","volume":"134","author":"Yu","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bjd.15236","article-title":"MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma","volume":"177","author":"Valero","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.7150\/thno.37455","article-title":"Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis","volume":"9","author":"He","year":"2019","journal-title":"Theranostics"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"112579","DOI":"10.1016\/j.yexcr.2021.112579","article-title":"MiR-205-5p suppresses angiogenesis in gastric cancer by downregulating the expression of VEGFA and FGF1","volume":"404","author":"Zhang","year":"2021","journal-title":"Exp. Cell Res."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Fukada, M., Matsuhashi, N., Takahashi, T., Sugito, N., Heishima, K., Akao, Y., and Yoshida, K. (2020). Tumor Tissue MIR92a and Plasma MIRs21 and 29a as Predictive Biomarkers Associated with Clinicopathological Features and Surgical Resection in a Prospective Study on Colorectal Cancer Patients. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082509"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Bouz Mkabaah, L., Davey, M.G., Lennon, J.C., Bouz, G., Miller, N., and Kerin, M.J. (2023). Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence-A Systematic Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087115"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Torres-Bustamante, M.I., Vazquez-Urrutia, J.R., Solorzano-Ibarra, F., and Ortiz-Lazareno, P.C. (2024). The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25042178"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1038\/s41598-017-05801-3","article-title":"MicroRNAs with prognostic significance in bladder cancer: A systematic review and meta-analysis","volume":"7","author":"Xie","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/modpathol.2017.62","article-title":"Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence","volume":"30","author":"Ganci","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Jayaraj, R., Polpaya, K., Kunale, M., Muthukaliannan, G.K., Shetty, S., Baxi, S., Mani, R.R., Paranjothy, C., Purushothaman, V., and Kayarohanam, S. (2022). Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis. Genes, 13.","DOI":"10.3390\/genes13122325"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Broseghini, E., Carosi, F., Berti, M., Compagno, S., Ghelardini, A., Fermi, M., Querzoli, G., and Filippini, D.M. (2025). Salivary Gland Cancers in the Era of Molecular Analysis: The Role of Tissue and Liquid Biomarkers. Cancers, 17.","DOI":"10.3390\/cancers17040660"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"731479","DOI":"10.1155\/2015\/731479","article-title":"Challenges in using circulating miRNAs as cancer biomarkers","volume":"2015","author":"Tiberio","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Roi, A., Boia, S., Rusu, L.-C., Roi, C.I., Boia, E.R., and Rivi\u0219, M. (2023). Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030965"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1002\/ctm2.585","article-title":"Challenges of microRNA-based biomarkers in clinical application for cardiovascular diseases","volume":"12","author":"Curado","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e70028","DOI":"10.1002\/wrna.70028","article-title":"MicroRNAs and Cancer Racial Disparities","volume":"16","author":"Zhao","year":"2025","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/carcin\/bgy134","article-title":"Differences in microRNA expression in breast cancer between women of African and European ancestry","volume":"40","author":"Gong","year":"2019","journal-title":"Carcinogenesis"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6101\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:17:45Z","timestamp":1783592265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":105,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27146101"],"URL":"https:\/\/doi.org\/10.3390\/ijms27146101","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]}}}